1. Review current guidelines for use of GBCA in CKD and what evidence supports this
2. Discuss the risk of iodinated contrast agents in CKD
3. Identify the limitations of CIN studies

4. Discover the impact of iodinated contrast agents on residual kidney function in ESRD

5. Describe the roles of the members of the health care team in their respective responsibilities for quality care


Jonathan Slater, MD

Session date: 
02/16/2018 - 12:00pm to 1:00pm EST
Baystate Medical Center
759 Chestnut St
Chicopee/Agawam Room
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.